Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
Factor VIII, Quantity: 500 IU
CSL Behring Australia Pty Ltd
Factor VIII
Injection, solution
Excipient Ingredients: water for injections
Intravenous
Human Coagulation Factor VIII is indicated for the treatment and prophylaxis of bleeding associated with factor VIII deficiency due to haemophilia A.
Visual Identification: Clear, colourless solution free from visible particles; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2006-10-26